BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30180957)

  • 1. Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.
    Gajanana D; Rogers T; Weintraub WS; Iantorno M; Buchanan KD; Ben-Dor I; Pichard AD; Satler LF; Thourani VH; Torguson R; Okubagzi PG; Waksman R
    Am J Cardiol; 2018 Nov; 122(9):1536-1540. PubMed ID: 30180957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
    Trujillo JF; Hollenberg SM
    FP Essent; 2017 Jun; 457():23-29. PubMed ID: 28671806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Bussey HI; Dalen JE; Turpie AG
    Chest; 2001 Jan; 119(1 Suppl):220S-227S. PubMed ID: 11157651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
    Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D
    Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing.
    Beller JP; Krebs ED; Hawkins RB; Mehaffey JH; Quader MA; Speir AM; Kiser AC; Joseph M; Yarboro LT; Teman NR; Ailawadi G
    J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1222-1231. PubMed ID: 31706560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI - State-of-the-art review.
    Gajanana D; Rogers T; Iantorno M; Buchanan KD; Ben-Dor I; Pichard AD; Satler LF; Torguson R; Okubagzi PG; Waksman R
    Int J Cardiol; 2018 Aug; 264():39-44. PubMed ID: 29685692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid- to long-term outcome comparison of the Medtronic Hancock II and bi-leaflet mechanical aortic valve replacement in patients younger than 60 years of age: a propensity-matched analysis.
    Wang Y; Chen S; Shi J; Li G; Dong N
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):280-6. PubMed ID: 26675564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early mortality after aortic valve replacement with mechanical prosthetic vs bioprosthetic valves among Medicare beneficiaries: a population-based cohort study.
    Du DT; McKean S; Kelman JA; Laschinger J; Johnson C; Warnock R; Worrall CM; Sedrakyan A; Encinosa W; MaCurdy TE; Izurieta HS
    JAMA Intern Med; 2014 Nov; 174(11):1788-95. PubMed ID: 25221895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements.
    Isaacs AJ; Shuhaiber J; Salemi A; Isom OW; Sedrakyan A
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1262-9.e3. PubMed ID: 25791947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.
    Iung B; Rodés-Cabau J
    Eur Heart J; 2014 Nov; 35(42):2942-9. PubMed ID: 25205532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
    Rubboli A; Agewall S; Huber K; Lip GY
    Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years.
    Chikwe J; Chiang YP; Egorova NN; Itagaki S; Adams DH
    JAMA; 2015 Apr; 313(14):1435-42. PubMed ID: 25871669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
    Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease.
    Hammermeister KE; Sethi GK; Henderson WG; Oprian C; Kim T; Rahimtoola S
    N Engl J Med; 1993 May; 328(18):1289-96. PubMed ID: 8469251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.